RT Catherine Simoneau
#nanotechnologies are key to green transition and for innovation in multiple domains!
We are most happy to contribute to #openaccess to boost the power of science & evidence for policy with our #nanobiotechnology laboratories @EU_ScienceHub
👉 https://joint-research-centre.ec.europa.eu/laboratories-and-facilities/jrc-nanobiotechnology-laboratory_en https://n.respublicae.eu/stephen_quest/status/1673318945695096832
<div class="rsshub-quote">
Stephen Quest: Great to meet @PiaSandvik at @RISEsweden and to sign our new scientific partnership.
Together, we will👉boost innovation &amp; green transition to maximise impact in
📂space &amp; security
📂cities &amp; buildings
📂#circulareconomy
📂future-oriented industrial policy
📂#openaccess
&amp; more! https://t.co/hbphIDy0kF
</div>

🐦🔗: https://n.respublicae.eu/Cath_Simoneau/status/1673325688949030919

Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases.

Friedreich’s ataxia represents a test case to validate the potential of therapeutic strategies based on nanoparticles.

#Neuroscience #Brain #NeurologicalDiseases #NeurodegenerativeDiseases #Neurodegeneration #Cerebellum #Ataxia #FriedreichAtaxia #HereditaryAtaxias #Ataxias #NeurogeneticDiseases #Neurogenetics
#Genetics #HereditaryDiseases #GeneticDiseases
#ClinicalTrial
#GeneTherapy
#Neuroinflammation
#Mitochondria #MitochondrialDysfunction
#Nanoparticles #Nanomedicine #Nanobiotechnology
#Biomedicine #Health
https://academic.oup.com/brain/article/doi/10.1093/brain/awad014/7024724

Next stop of #GabrielMariya's visit at our Ispra site today – the #Nanobiotechnology Laboratory.
Nanotechnology can help to address some of the biggest challenges faced by society, such as energy supply or health care.
❓How? Take a virtual tour
👇
https://europa.eu/!uc68GF

🐦🔗: https://n.respublicae.eu/EU_ScienceHub/status/1651573198738079745